FOLIC ACID

FOLIC ACID was reported 250984 times

FOLIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5634 0.7856
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 503 0.7530
2 SWOLLEN JOINT COUNT INCREASED 2349 0.7359
3 PEMPHIGUS 9207 0.7357
4 RHEUMATIC FEVER 3163 0.7089
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1390 0.6940
6 DUODENAL ULCER PERFORATION 5130 0.6891
7 RHEUMATOID FACTOR POSITIVE 3766 0.6513
8 C-REACTIVE PROTEIN 592 0.6386
9 LUPUS VULGARIS 786 0.6238
10 HAND DEFORMITY 7763 0.5913
11 FACET JOINT SYNDROME 1919 0.5888
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1043 0.5029
13 HELICOBACTER INFECTION 5134 0.4990
14 DISLOCATION OF VERTEBRA 1051 0.4604
15 X-RAY ABNORMAL 790 0.4413
16 SYNOVITIS 7726 0.4281
17 MUSCLE INJURY 3549 0.4279
18 C-REACTIVE PROTEIN ABNORMAL 2705 0.4213
19 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2639 0.4059
20 RETINITIS 674 0.3898
21 FOLLICULITIS 4059 0.3867
22 GLOSSODYNIA 8662 0.3865
23 PERICARDITIS 6305 0.3749
24 PERIPHERAL VENOUS DISEASE 1464 0.3581
25 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 197 0.3512
26 BLOOD PRESSURE SYSTOLIC ABNORMAL 847 0.3424
27 BLOOD PRESSURE DIASTOLIC ABNORMAL 854 0.3354
28 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 753 0.3265
29 SERONEGATIVE ARTHRITIS 368 0.3211
30 BONE EROSION 1033 0.2918
31 SYSTEMIC LUPUS ERYTHEMATOSUS 10291 0.2897
32 WOUND 7648 0.2733
33 GRANULOMA SKIN 212 0.2582
34 CONTRAINDICATED PRODUCT ADMINISTERED 7407 0.2444
35 JOINT DESTRUCTION 368 0.2365
36 BREAST CANCER STAGE III 1511 0.2331
37 ENTHESOPATHY 357 0.2281
38 DRUG TOLERANCE DECREASED 641 0.2280
39 GRIP STRENGTH DECREASED 1907 0.2165
40 JOINT RANGE OF MOTION DECREASED 2871 0.2139
41 LIP DRY 1903 0.2093
42 PORPHYRIA ACUTE 296 0.2063
43 ONYCHOMADESIS 856 0.2038
44 LIVE BIRTH 1664 0.1987
45 HYPERCHOLESTEROLAEMIA 1894 0.1960
46 BURSITIS 2368 0.1950
47 RHEUMATOID NODULE 537 0.1948
48 IRRITABLE BOWEL SYNDROME 4119 0.1919
49 WOUND INFECTION 2088 0.1905
50 ARTHROPATHY 9602 0.1726
51 ONYCHOMYCOSIS 754 0.1717
52 FIBROMYALGIA 4114 0.1691
53 BLOOD PARATHYROID HORMONE DECREASED 244 0.1645
54 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1771 0.1599
55 RHEUMATOID ARTHRITIS 18094 0.1592
56 TENOSYNOVITIS 429 0.1554
57 FINGER DEFORMITY 753 0.1553
58 IMPAIRED HEALING 5032 0.1531
59 AUTOIMMUNE DISORDER 1491 0.1528
60 DEATH NEONATAL 209 0.1501
61 BLEPHAROSPASM 920 0.1460
62 PSORIATIC ARTHROPATHY 5818 0.1432
63 INFUSION RELATED REACTION 9038 0.1362
64 LIVER INJURY 3266 0.1329
65 FOOT DEFORMITY 1472 0.1327
66 EXOSTOSIS 1148 0.1256
67 HIP ARTHROPLASTY 1924 0.1255
68 SCIATICA 2002 0.1255
69 OBESITY 1967 0.1233
70 MATERNAL EXPOSURE TIMING UNSPECIFIED 457 0.1215
71 DYSMORPHISM 285 0.1209
72 TYPE 2 DIABETES MELLITUS 4046 0.1201
73 THERAPEUTIC PRODUCT EFFECT DECREASED 5333 0.1189
74 LOWER RESPIRATORY TRACT INFECTION 5359 0.1177
75 NAIL DISORDER 1026 0.1172
76 BLOOD PRESSURE DIASTOLIC DECREASED 865 0.1171
77 PULMONARY FIBROSIS 2237 0.1165
78 OSTEOARTHRITIS 4838 0.1140
79 HEPATIC ENZYME INCREASED 7378 0.1081
80 DISCOMFORT 6552 0.1073
81 JOINT EFFUSION 739 0.1071
82 INFUSION SITE REACTION 319 0.1067
83 ALANINE AMINOTRANSFERASE ABNORMAL 225 0.1066
84 PANNICULITIS 258 0.1065
85 KNEE ARTHROPLASTY 2218 0.1052
86 SWELLING 9581 0.1023
87 BLOOD PRESSURE DIASTOLIC INCREASED 469 0.1015
88 C-REACTIVE PROTEIN INCREASED 3681 0.1011
89 POLYARTHRITIS 529 0.1002
90 JOINT DISLOCATION 1059 0.1001
91 LUPUS-LIKE SYNDROME 901 0.0993
92 BLOOD PRESSURE SYSTOLIC INCREASED 1933 0.0990
93 JOINT SWELLING 11899 0.0985
94 MATERNAL EXPOSURE DURING PREGNANCY 8766 0.0982
95 WALKING AID USER 640 0.0970
96 BLISTER 5249 0.0934
97 SPONDYLITIS 333 0.0915
98 BLOOD CHOLESTEROL INCREASED 4239 0.0908
99 PUSTULAR PSORIASIS 311 0.0905
100 JUVENILE IDIOPATHIC ARTHRITIS 217 0.0886
101 SICKLE CELL ANAEMIA WITH CRISIS 1375 0.0872
102 DRUG INTOLERANCE 8392 0.0868
103 STOMATITIS 5211 0.0858
104 LOWER LIMB FRACTURE 1646 0.0856
105 MUSCULOSKELETAL STIFFNESS 7306 0.0833
106 PRESCRIBED OVERDOSE 1610 0.0831
107 GESTATIONAL DIABETES 392 0.0822
108 PLEURITIC PAIN 227 0.0822
109 SYNOVIAL CYST 377 0.0816
110 SMALL FOR DATES BABY 402 0.0809
111 INFLAMMATION 4171 0.0807
112 BLOOD PRESSURE FLUCTUATION 1893 0.0788
113 GAIT INABILITY 2627 0.0785
114 BODY TEMPERATURE DECREASED 759 0.0770
115 BACK INJURY 837 0.0769
116 CONGENITAL ANOMALY 590 0.0761
117 JOINT STIFFNESS 1945 0.0741
118 DRUG TOLERANCE 372 0.0735
119 ABDOMINAL DISCOMFORT 12118 0.0722
120 ULCER HAEMORRHAGE 482 0.0712
121 MOBILITY DECREASED 5105 0.0710
122 ARTHRITIS INFECTIVE 329 0.0709
123 AORTIC ARTERIOSCLEROSIS 182 0.0707
124 TREATMENT FAILURE 5836 0.0704
125 CUSHINGOID 225 0.0700
126 NIGHT SWEATS 2231 0.0692
127 NORMAL NEWBORN 375 0.0689
128 RED CELL DISTRIBUTION WIDTH INCREASED 285 0.0685
129 SPINAL STENOSIS 283 0.0685
130 SINUSITIS 6976 0.0680
131 PRODUCT LABEL CONFUSION 395 0.0677
132 PREGNANCY 1352 0.0675
133 MUSCULOSKELETAL PAIN 3506 0.0669
134 PRESCRIBED UNDERDOSE 1324 0.0663
135 HEPATIC CIRRHOSIS 1246 0.0662
136 COELIAC DISEASE 643 0.0655
137 EXPOSURE DURING PREGNANCY 4067 0.0654
138 NECK MASS 185 0.0653
139 ANTINUCLEAR ANTIBODY POSITIVE 212 0.0652
140 SERUM FERRITIN INCREASED 344 0.0652
141 WHEEZING 3823 0.0644
142 NEPHROGENIC ANAEMIA 295 0.0636
143 LIVER FUNCTION TEST INCREASED 1356 0.0631
144 PULMONARY PAIN 184 0.0630
145 BRONCHIECTASIS 424 0.0629
146 NODULE 818 0.0626
147 EYE INJURY 189 0.0622
148 ILL-DEFINED DISORDER 3777 0.0621
149 INTERVERTEBRAL DISC DEGENERATION 573 0.0619
150 NEONATAL RESPIRATORY DISTRESS SYNDROME 218 0.0615
151 INTENTIONAL PRODUCT USE ISSUE 5371 0.0612
152 ALOPECIA 12024 0.0612
153 OEDEMA 3315 0.0611
154 IMMUNODEFICIENCY 903 0.0605
155 SPINAL FUSION SURGERY 245 0.0603
156 BASAL CELL CARCINOMA 940 0.0602
157 SPINAL OSTEOARTHRITIS 528 0.0600
158 BREAST CANCER STAGE II 500 0.0600
159 INFLAMMATORY MARKER INCREASED 297 0.0599
160 VENTRICULAR SEPTAL DEFECT 341 0.0595
161 TENDERNESS 613 0.0588
162 RASH VESICULAR 282 0.0583
163 EAR INFECTION 1551 0.0582
164 ATRIAL SEPTAL DEFECT 488 0.0582
165 CONTUSION 5605 0.0582
166 GENERAL PHYSICAL HEALTH DETERIORATION 6722 0.0580
167 PREMATURE LABOUR 327 0.0578
168 PRE-ECLAMPSIA 273 0.0574
169 LUNG DISORDER 2798 0.0570
170 ARTHRITIS 4477 0.0569
171 ANAL FISSURE 305 0.0568
172 ARTHRITIS BACTERIAL 233 0.0567
173 MATERNAL EXPOSURE BEFORE PREGNANCY 387 0.0566
174 LOW BIRTH WEIGHT BABY 450 0.0566
175 POSTOPERATIVE WOUND INFECTION 381 0.0564
176 POOR VENOUS ACCESS 582 0.0562
177 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2694 0.0560
178 PERIPHERAL SWELLING 8483 0.0550
179 SKIN NECROSIS 285 0.0549
180 BREATH SOUNDS ABNORMAL 268 0.0543
181 HAEMOLYSIS 419 0.0542
182 CHRONIC SINUSITIS 201 0.0535
183 WHEELCHAIR USER 238 0.0535
184 OSTEOPOROSIS 2188 0.0531
185 NASOPHARYNGITIS 9747 0.0528
186 INJURY 3687 0.0524
187 ROAD TRAFFIC ACCIDENT 2162 0.0516
188 IRON DEFICIENCY 232 0.0515
189 CARDIAC MURMUR 443 0.0511
190 GASTROINTESTINAL DISORDER 4575 0.0510
191 EAR PAIN 988 0.0508
192 HAEMATOCRIT DECREASED 1001 0.0504
193 HEART RATE DECREASED 1766 0.0502
194 SLEEP DISORDER 3523 0.0499
195 TASTE DISORDER 1012 0.0498
196 MONOCYTE COUNT INCREASED 181 0.0498
197 INFECTION 7193 0.0496
198 FOETAL GROWTH RESTRICTION 301 0.0495
199 MENISCUS INJURY 299 0.0486
200 ARTHRALGIA 20195 0.0485
201 VITAMIN B12 DEFICIENCY 196 0.0484
202 PATENT DUCTUS ARTERIOSUS 191 0.0481
203 RHINITIS 385 0.0477
204 THERAPY NON-RESPONDER 2144 0.0476
205 SKIN PAPILLOMA 191 0.0476
206 APHTHOUS ULCER 369 0.0475
207 UMBILICAL HERNIA 222 0.0475
208 FOOT OPERATION 235 0.0474
209 EPILEPSY 1445 0.0472
210 INJECTION SITE PAPULE 216 0.0472
211 LIVER DISORDER 2093 0.0471
212 LOCALISED INFECTION 1131 0.0467
213 CAESAREAN SECTION 542 0.0465
214 CARPAL TUNNEL SYNDROME 649 0.0463
215 TONGUE DISORDER 334 0.0461
216 STILLBIRTH 223 0.0461
217 SPINAL COLUMN STENOSIS 218 0.0461
218 MOUTH ULCERATION 970 0.0460
219 UPPER RESPIRATORY TRACT INFECTION 2109 0.0456
220 SENSITIVITY TO WEATHER CHANGE 240 0.0456
221 HYPERSENSITIVITY 8435 0.0454
222 MATERNAL DRUGS AFFECTING FOETUS 347 0.0452
223 RESPIRATORY RATE INCREASED 399 0.0449
224 POST PROCEDURAL INFECTION 365 0.0448
225 SKIN ULCER 1159 0.0448
226 ANAL FISTULA 236 0.0442
227 SKIN ABRASION 209 0.0442
228 ATELECTASIS 427 0.0441
229 FOETAL EXPOSURE DURING PREGNANCY 3586 0.0441
230 ROTATOR CUFF SYNDROME 565 0.0440
231 DIVERTICULUM INTESTINAL 192 0.0439
232 ULCER 696 0.0437
233 RENAL CYST 347 0.0436
234 LIGAMENT RUPTURE 193 0.0436
235 PHARYNGITIS 540 0.0435
236 PANCYTOPENIA 2419 0.0432
237 RESPIRATORY TRACT INFECTION 1119 0.0429
238 HIATUS HERNIA 556 0.0429
239 LUNG NEOPLASM 183 0.0428
240 DELIRIUM 1487 0.0428
241 BRONCHITIS 3166 0.0427
242 VITAMIN D DECREASED 362 0.0423
243 OXYGEN SATURATION DECREASED 2378 0.0423
244 APLASTIC ANAEMIA 221 0.0423
245 TOOTH INFECTION 557 0.0422
246 HEPATITIS 1081 0.0422
247 HAEMOGLOBIN DECREASED 4336 0.0422
248 NECK PAIN 2351 0.0420
249 DISABILITY 826 0.0417
250 BLOOD ALBUMIN DECREASED 330 0.0416
251 IMMUNOSUPPRESSION 366 0.0414
252 DRY MOUTH 3360 0.0414
253 SKIN LACERATION 450 0.0413
254 FREQUENT BOWEL MOVEMENTS 1117 0.0413
255 JOINT INJURY 880 0.0412
256 DRUG-INDUCED LIVER INJURY 1287 0.0410
257 PULMONARY MASS 610 0.0409
258 TOOTH ABSCESS 415 0.0407
259 SQUAMOUS CELL CARCINOMA OF SKIN 246 0.0407
260 TIBIA FRACTURE 191 0.0407
261 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 696 0.0406
262 GINGIVAL PAIN 323 0.0405
263 FOETAL DEATH 210 0.0405
264 MYOSITIS 362 0.0403
265 NERVE COMPRESSION 372 0.0403
266 VITAMIN D DEFICIENCY 392 0.0402
267 HYPERCALCAEMIA 495 0.0400
268 CONFUSIONAL STATE 6471 0.0400
269 TENDONITIS 615 0.0397
270 SCOLIOSIS 246 0.0397
271 ANKYLOSING SPONDYLITIS 523 0.0396
272 CYST 491 0.0395
273 CELLULITIS 1989 0.0394
274 PLATELET COUNT INCREASED 514 0.0394
275 ADRENAL INSUFFICIENCY 475 0.0391
276 DIVERTICULUM 278 0.0391
277 WEIGHT INCREASED 8728 0.0389
278 HYPOAESTHESIA 5833 0.0389
279 NEUTROPENIC SEPSIS 278 0.0389
280 PAIN 23891 0.0389
281 GASTROENTERITIS VIRAL 701 0.0388
282 SINUS CONGESTION 524 0.0387
283 HYPERTENSION 8188 0.0386
284 INGUINAL HERNIA 235 0.0386
285 HUMERUS FRACTURE 186 0.0385
286 BLOOD IRON DECREASED 456 0.0384
287 SKIN INFECTION 430 0.0383
288 CONDITION AGGRAVATED 11654 0.0383
289 TONSILLITIS 200 0.0383
290 RED BLOOD CELL COUNT DECREASED 1095 0.0383
291 PELVIC FRACTURE 298 0.0382
292 SPINAL DISORDER 360 0.0380
293 HYPERKERATOSIS 209 0.0378
294 HEPATIC STEATOSIS 705 0.0378
295 BENIGN PROSTATIC HYPERPLASIA 195 0.0377
296 PRODUCT USE ISSUE 7083 0.0376
297 AUTISM SPECTRUM DISORDER 207 0.0376
298 GASTROENTERITIS 545 0.0373
299 OSTEOPENIA 564 0.0371
300 PAIN IN EXTREMITY 10943 0.0371
301 HERPES ZOSTER 2113 0.0367
302 PREMATURE DELIVERY 583 0.0366
303 MASS 510 0.0365
304 SPLENOMEGALY 427 0.0364
305 IRON DEFICIENCY ANAEMIA 336 0.0364
306 BLOOD MAGNESIUM DECREASED 313 0.0362
307 OEDEMA PERIPHERAL 4416 0.0362
308 GASTROOESOPHAGEAL REFLUX DISEASE 2914 0.0362
309 ARTHROPOD BITE 268 0.0361
310 VASCULITIS 421 0.0361
311 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2569 0.0361
312 WEIGHT FLUCTUATION 377 0.0360
313 FOOT FRACTURE 682 0.0359
314 DYSPEPSIA 3537 0.0359
315 DRUG LEVEL BELOW THERAPEUTIC 197 0.0357
316 UVEITIS 482 0.0355
317 LIGAMENT SPRAIN 349 0.0353
318 PNEUMONIA 11397 0.0352
319 PLEURISY 209 0.0352
320 PREMATURE BABY 1058 0.0351
321 HAND FRACTURE 249 0.0351
322 INCREASED TENDENCY TO BRUISE 322 0.0350
323 DIVERTICULITIS 966 0.0348
324 WHITE BLOOD CELL COUNT INCREASED 1335 0.0348
325 CYSTITIS 1108 0.0348
326 MALIGNANT MELANOMA 463 0.0345
327 ANAL ABSCESS 186 0.0345
328 MIGRAINE 3294 0.0345
329 INTERVERTEBRAL DISC PROTRUSION 750 0.0343
330 ABORTION SPONTANEOUS 1373 0.0342
331 FLANK PAIN 321 0.0342
332 BONE DISORDER 624 0.0342
333 POLYP 224 0.0342
334 SQUAMOUS CELL CARCINOMA 322 0.0342
335 ORAL CANDIDIASIS 450 0.0341
336 ORAL HERPES 663 0.0339
337 DRUG EXPOSURE DURING PREGNANCY 1150 0.0338
338 SPINAL PAIN 396 0.0338
339 KIDNEY INFECTION 658 0.0335
340 ARTERIOSCLEROSIS CORONARY ARTERY 222 0.0335
341 HAEMOGLOBIN ABNORMAL 214 0.0332
342 TRICUSPID VALVE INCOMPETENCE 264 0.0332
343 FISTULA 372 0.0331
344 BACK DISORDER 538 0.0331
345 RECTAL HAEMORRHAGE 1420 0.0330
346 TOOTH FRACTURE 363 0.0329
347 TENDON DISORDER 213 0.0326
348 OROPHARYNGEAL PAIN 3017 0.0326
349 GASTROINTESTINAL INFECTION 292 0.0325
350 RASH 14198 0.0325
351 LIMB INJURY 884 0.0325
352 LOCAL SWELLING 564 0.0323
353 INJECTION SITE HAEMATOMA 469 0.0323
354 PYREXIA 11092 0.0320
355 SPUTUM DISCOLOURED 304 0.0320
356 OVARIAN CYST 320 0.0320
357 UROSEPSIS 294 0.0318
358 PHARYNGITIS STREPTOCOCCAL 344 0.0318
359 GROIN PAIN 279 0.0317
360 MUSCULOSKELETAL DISCOMFORT 546 0.0317
361 PRODUCTIVE COUGH 1510 0.0316
362 OSTEOMYELITIS 571 0.0315
363 CROHN'S DISEASE 216 0.0315
364 MITRAL VALVE INCOMPETENCE 355 0.0313
365 URINARY TRACT INFECTION 5349 0.0313
366 EMPHYSEMA 316 0.0313
367 RESPIRATORY TRACT CONGESTION 495 0.0311
368 CARDIOMEGALY 383 0.0311
369 ESCHERICHIA INFECTION 256 0.0311
370 FATIGUE 24217 0.0311
371 MUSCULOSKELETAL CHEST PAIN 479 0.0309
372 GASTRITIS 813 0.0309
373 MUSCULAR WEAKNESS 3506 0.0308
374 ODYNOPHAGIA 184 0.0308
375 FEAR OF INJECTION 219 0.0307
376 PAROSMIA 231 0.0306
377 BODY TEMPERATURE INCREASED 620 0.0304
378 HEART RATE IRREGULAR 686 0.0303
379 GAIT DISTURBANCE 5810 0.0303
380 RIB FRACTURE 624 0.0303
381 CHEST PAIN 5615 0.0303
382 LACERATION 285 0.0303
383 FULL BLOOD COUNT ABNORMAL 320 0.0302
384 BREAST MASS 203 0.0302
385 MUCOSAL INFLAMMATION 791 0.0302
386 ABSCESS 481 0.0301
387 SMALL INTESTINAL OBSTRUCTION 371 0.0301
388 WRIST FRACTURE 361 0.0301
389 SPINAL COMPRESSION FRACTURE 248 0.0300
390 ANAEMIA 5692 0.0298
391 FEMUR FRACTURE 924 0.0298
392 BLOOD PRESSURE INCREASED 4539 0.0297
393 TOOTHACHE 537 0.0296
394 VIRAL INFECTION 987 0.0296
395 PYELONEPHRITIS 257 0.0296
396 GASTROINTESTINAL INFLAMMATION 232 0.0296
397 CHOLELITHIASIS 971 0.0296
398 BLOOD TEST ABNORMAL 416 0.0296
399 RHINORRHOEA 1909 0.0295
400 MUSCLE STRAIN 255 0.0294
401 SEASONAL ALLERGY 417 0.0294
402 WEIGHT DECREASED 8212 0.0294
403 ADVERSE REACTION 390 0.0294
404 HAEMORRHOIDS 573 0.0293
405 ASTHMA 3304 0.0292
406 ENTERITIS 187 0.0292
407 RESPIRATORY DISORDER 874 0.0292
408 FURUNCLE 231 0.0291
409 INFLUENZA 3250 0.0291
410 SLEEP APNOEA SYNDROME 556 0.0291
411 CATARACT 1734 0.0291
412 LUNG INFILTRATION 257 0.0291
413 MUSCULOSKELETAL DISORDER 552 0.0290
414 TENDON RUPTURE 358 0.0290
415 PSORIASIS 3783 0.0289
416 ANKLE FRACTURE 448 0.0289
417 TRANSFUSION 302 0.0288
418 HEPATIC CYTOLYSIS 367 0.0288
419 ABDOMINAL PAIN UPPER 5901 0.0286
420 END STAGE RENAL DISEASE 522 0.0286
421 HEPATOMEGALY 281 0.0286
422 DECUBITUS ULCER 233 0.0286
423 LIVER FUNCTION TEST ABNORMAL 831 0.0285
424 CORONARY ARTERY OCCLUSION 391 0.0285
425 AMNESIA 1854 0.0285
426 BLOOD LACTATE DEHYDROGENASE INCREASED 451 0.0284
427 FAECES SOFT 207 0.0284
428 EYE INFECTION 321 0.0284
429 NEPHROLITHIASIS 1303 0.0284
430 HAEMATOCHEZIA 1561 0.0283
431 OESOPHAGITIS 309 0.0283
432 INJECTION SITE REACTION 1944 0.0282
433 SEPTIC SHOCK 1228 0.0282
434 GASTRIC ULCER 536 0.0282
435 NASAL CONGESTION 1656 0.0282
436 LARGE INTESTINE POLYP 195 0.0281
437 DYSPNOEA EXERTIONAL 1060 0.0281
438 HAEMOLYTIC ANAEMIA 252 0.0281
439 GOUT 504 0.0281
440 BLOOD URINE PRESENT 533 0.0280
441 TOOTH DISORDER 623 0.0280
442 UTERINE LEIOMYOMA 204 0.0279
443 INJECTION SITE IRRITATION 355 0.0279
444 COLITIS ULCERATIVE 1239 0.0277
445 RENAL FAILURE CHRONIC 213 0.0277
446 ABDOMINAL PAIN 6439 0.0277
447 HERNIA 535 0.0276
448 DEFORMITY 258 0.0276
449 FALL 9171 0.0275
450 DECREASED APPETITE 6384 0.0275
451 RASH PRURITIC 1480 0.0273
452 MEDICATION ERROR 1512 0.0272
453 HYPOKALAEMIA 1255 0.0272
454 UPPER-AIRWAY COUGH SYNDROME 224 0.0272
455 SKIN LESION 745 0.0271
456 INJECTION SITE WARMTH 558 0.0271
457 DRUG LEVEL DECREASED 276 0.0271
458 INJECTION SITE EXTRAVASATION 334 0.0270
459 HYPERAESTHESIA 222 0.0270
460 PLEURAL EFFUSION 1641 0.0269
461 UPPER LIMB FRACTURE 537 0.0269
462 PETECHIAE 281 0.0269
463 DRUG ERUPTION 477 0.0269
464 INJECTION SITE PRURITUS 1801 0.0269
465 NEUTROPHIL COUNT INCREASED 275 0.0268
466 DENTAL CARIES 297 0.0268
467 BLOOD POTASSIUM DECREASED 806 0.0268
468 MALNUTRITION 299 0.0267
469 STAPHYLOCOCCAL INFECTION 880 0.0267
470 URTICARIA 4459 0.0266
471 HYDRONEPHROSIS 199 0.0266
472 IMMUNE SYSTEM DISORDER 349 0.0265
473 ECCHYMOSIS 181 0.0264
474 CLOSTRIDIUM DIFFICILE INFECTION 576 0.0264
475 PNEUMOCYSTIS JIROVECII PNEUMONIA 264 0.0263
476 MYELODYSPLASTIC SYNDROME 378 0.0261
477 URINE OUTPUT DECREASED 228 0.0261
478 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1360 0.0260
479 COUGH 7296 0.0260
480 GENERAL SYMPTOM 195 0.0260
481 BACK PAIN 6031 0.0259
482 ARTERIOSCLEROSIS 244 0.0259
483 BLOOD UREA INCREASED 434 0.0259
484 ORAL PAIN 580 0.0259
485 APHONIA 361 0.0258
486 PARAESTHESIA 4069 0.0258
487 SUPRAVENTRICULAR TACHYCARDIA 246 0.0257
488 PHOTOPHOBIA 483 0.0257
489 SECRETION DISCHARGE 321 0.0256
490 IMPAIRED QUALITY OF LIFE 368 0.0256
491 BACTERIAL INFECTION 476 0.0255
492 CONJUNCTIVITIS 471 0.0254
493 AORTIC ANEURYSM 193 0.0253
494 ALANINE AMINOTRANSFERASE INCREASED 1553 0.0253
495 HYPERLIPIDAEMIA 302 0.0252
496 RASH PUSTULAR 183 0.0251
497 THERAPEUTIC RESPONSE DECREASED 1522 0.0251
498 OBSTRUCTIVE AIRWAYS DISORDER 279 0.0251
499 COVID-19 PNEUMONIA 296 0.0250
500 ATRIAL FLUTTER 200 0.0250
501 CANDIDA INFECTION 423 0.0250
502 HYPOCALCAEMIA 474 0.0250
503 DYSSTASIA 730 0.0250
504 BLOOD SODIUM DECREASED 471 0.0250
505 DECREASED IMMUNE RESPONSIVENESS 245 0.0249
506 ASTHENIA 9386 0.0249
507 LYMPHADENOPATHY 883 0.0249
508 MEMORY IMPAIRMENT 3419 0.0249
509 SEPSIS 2766 0.0248
510 NEURALGIA 603 0.0248
511 LIMB DISCOMFORT 766 0.0247
512 LUNG INFECTION 384 0.0247
513 TUBULOINTERSTITIAL NEPHRITIS 462 0.0246
514 FRACTURE 465 0.0245
515 CHROMATURIA 554 0.0245
516 DYSPNOEA 13870 0.0245
517 PNEUMONIA ASPIRATION 612 0.0245
518 PNEUMONITIS 667 0.0245
519 BLOOD CALCIUM DECREASED 275 0.0244
520 POST PROCEDURAL COMPLICATION 469 0.0244
521 KNEE OPERATION 240 0.0244
522 SKIN CANCER 525 0.0244
523 VOMITING 11434 0.0243
524 PROCEDURAL COMPLICATION 186 0.0242
525 BODY HEIGHT DECREASED 259 0.0242
526 CONCUSSION 187 0.0241
527 ELECTROCARDIOGRAM ABNORMAL 189 0.0241
528 FUNGAL INFECTION 800 0.0240
529 IMPAIRED WORK ABILITY 513 0.0240
530 GLAUCOMA 462 0.0240
531 COLITIS 900 0.0237
532 HYPOMAGNESAEMIA 330 0.0237
533 ANAL INCONTINENCE 213 0.0237
534 HEADACHE 14794 0.0236
535 ACUTE RESPIRATORY FAILURE 453 0.0235
536 MALAISE 10309 0.0235
537 PULMONARY HYPERTENSION 489 0.0235
538 CLOSTRIDIUM DIFFICILE COLITIS 248 0.0234
539 BLOOD CREATININE INCREASED 1527 0.0234
540 UPPER GASTROINTESTINAL HAEMORRHAGE 391 0.0232
541 THROMBOCYTOPENIA 2595 0.0232
542 HYSTERECTOMY 200 0.0231
543 EAR DISCOMFORT 237 0.0231
544 TRANSIENT ISCHAEMIC ATTACK 779 0.0231
545 LABORATORY TEST ABNORMAL 681 0.0231
546 LYMPHOCYTE COUNT DECREASED 407 0.0230
547 ADVERSE EVENT 2121 0.0230
548 ABDOMINAL DISTENSION 2399 0.0230
549 DIARRHOEA 14827 0.0229
550 NEPHROPATHY 214 0.0229
551 ELECTROLYTE IMBALANCE 266 0.0229
552 ASPARTATE AMINOTRANSFERASE INCREASED 1212 0.0228
553 PLATELET COUNT DECREASED 2430 0.0228
554 PERICARDIAL EFFUSION 527 0.0228
555 DERMATITIS ALLERGIC 286 0.0227
556 SENSORY LOSS 183 0.0227
557 INJECTION SITE DISCOLOURATION 284 0.0227
558 INFUSION SITE PAIN 292 0.0226
559 MUSCLE SPASMS 4154 0.0226
560 BONE MARROW FAILURE 460 0.0226
561 LEUKOPENIA 1132 0.0226
562 ATRIAL FIBRILLATION 2202 0.0226
563 DEPRESSION 5141 0.0226
564 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 382 0.0225
565 PALLOR 611 0.0224
566 SCAB 256 0.0224
567 PNEUMONIA BACTERIAL 206 0.0224
568 ADVERSE DRUG REACTION 2014 0.0224
569 FLUID RETENTION 1140 0.0224
570 DIARRHOEA HAEMORRHAGIC 209 0.0223
571 THROAT IRRITATION 1001 0.0223
572 DEHYDRATION 2969 0.0222
573 FEELING HOT 1361 0.0222
574 TOOTH EXTRACTION 275 0.0221
575 INJECTION SITE ERYTHEMA 2740 0.0221
576 INTERSTITIAL LUNG DISEASE 1069 0.0221
577 GALLBLADDER DISORDER 394 0.0221
578 BLOOD COUNT ABNORMAL 334 0.0220
579 BLOOD CALCIUM INCREASED 193 0.0220
580 SINUS DISORDER 434 0.0219
581 ACUTE KIDNEY INJURY 3353 0.0219
582 INTESTINAL OBSTRUCTION 824 0.0218
583 PRURITUS 8395 0.0218
584 FACIAL PAIN 195 0.0218
585 PULMONARY CONGESTION 287 0.0217
586 DIZZINESS POSTURAL 211 0.0217
587 SPINAL OPERATION 268 0.0217
588 INTERNATIONAL NORMALISED RATIO INCREASED 618 0.0217
589 ASPIRATION 237 0.0216
590 BLOOD POTASSIUM INCREASED 351 0.0216
591 INSOMNIA 5756 0.0216
592 PULMONARY THROMBOSIS 235 0.0215
593 INJECTION SITE BRUISING 1718 0.0215
594 HYPOTENSION 4316 0.0215
595 MOVEMENT DISORDER 689 0.0214
596 DYSURIA 788 0.0214
597 INTESTINAL PERFORATION 240 0.0214
598 DRY THROAT 217 0.0213
599 SKIN DISCOLOURATION 980 0.0213
600 SPINAL FRACTURE 426 0.0212
601 EPISTAXIS 1590 0.0212
602 HYPERKALAEMIA 745 0.0212
603 CORONARY ARTERY DISEASE 642 0.0212
604 INCONTINENCE 224 0.0212
605 MYOCARDIAL ISCHAEMIA 241 0.0212
606 HYPOKINESIA 307 0.0211
607 ABORTION INDUCED 199 0.0211
608 GINGIVAL BLEEDING 288 0.0211
609 CHOLECYSTITIS 251 0.0210
610 OFF LABEL USE 18427 0.0210
611 EYE INFLAMMATION 200 0.0209
612 HEART RATE INCREASED 2076 0.0209
613 PULMONARY OEDEMA 938 0.0209
614 INJECTION SITE RASH 640 0.0208
615 THYROID DISORDER 321 0.0208
616 RENAL TUBULAR NECROSIS 204 0.0208
617 HAEMATURIA 710 0.0207
618 LYMPHOMA 320 0.0207
619 DIZZINESS 10325 0.0207
620 TRANSAMINASES INCREASED 460 0.0207
621 PURPURA 183 0.0207
622 HYPONATRAEMIA 1164 0.0206
623 HYPOPHAGIA 528 0.0206
624 RENAL FAILURE ACUTE 876 0.0206
625 HYPOTHYROIDISM 658 0.0206
626 NOCTURIA 250 0.0206
627 HYPERTENSIVE CRISIS 229 0.0206
628 PROCEDURAL PAIN 571 0.0206
629 NAUSEA 16256 0.0205
630 INJECTION SITE NODULE 226 0.0205
631 DEVICE RELATED INFECTION 316 0.0205
632 MUSCLE SPASTICITY 252 0.0205
633 FEELING COLD 571 0.0205
634 APPENDICITIS 191 0.0204
635 FULL BLOOD COUNT DECREASED 412 0.0204
636 GENERALISED OEDEMA 252 0.0203
637 CHOLECYSTECTOMY 232 0.0203
638 BACTERAEMIA 241 0.0203
639 CHILLS 2378 0.0203
640 MACULAR DEGENERATION 242 0.0202
641 BLOOD PRESSURE ABNORMAL 402 0.0202
642 FAECES DISCOLOURED 438 0.0202
643 INJECTION SITE PAIN 6193 0.0202
644 PHOTOSENSITIVITY REACTION 333 0.0201
645 HIP FRACTURE 648 0.0201
646 PULMONARY EMBOLISM 1914 0.0201
647 INJECTION SITE SWELLING 1538 0.0201
648 WHITE BLOOD CELL COUNT DECREASED 2173 0.0200
649 LEUKOCYTOSIS 362 0.0200
650 SKIN DISORDER 667 0.0200
651 DRY EYE 996 0.0199
652 SARS-COV-2 TEST POSITIVE 262 0.0198
653 INJECTION SITE URTICARIA 486 0.0198
654 MICTURITION URGENCY 226 0.0198
655 CHRONIC KIDNEY DISEASE 1503 0.0198
656 WRONG TECHNIQUE IN DRUG USAGE PROCESS 718 0.0197
657 ACUTE MYOCARDIAL INFARCTION 580 0.0196
658 DEEP VEIN THROMBOSIS 1276 0.0196
659 HYPOTONIA 195 0.0195
660 EYE DISORDER 642 0.0195
661 PERIPHERAL COLDNESS 268 0.0195
662 INJECTION SITE INDURATION 253 0.0195
663 SINUS TACHYCARDIA 276 0.0194
664 RASH MACULO-PAPULAR 432 0.0194
665 DRUG INEFFECTIVE 25501 0.0193
666 TACHYCARDIA 1718 0.0193
667 NERVE INJURY 215 0.0193
668 THROMBOSIS 1554 0.0193
669 HYPERSOMNIA 553 0.0193
670 GASTROINTESTINAL PAIN 212 0.0192
671 HAEMATOMA 499 0.0192
672 PAIN IN JAW 545 0.0192
673 POOR QUALITY SLEEP 413 0.0192
674 SWOLLEN TONGUE 599 0.0192
675 PANCREATITIS 1012 0.0191
676 RASH PAPULAR 429 0.0191
677 SNEEZING 429 0.0191
678 BLOOD ALKALINE PHOSPHATASE INCREASED 475 0.0191
679 HAEMATEMESIS 484 0.0191
680 SCAR 325 0.0190
681 URINARY INCONTINENCE 561 0.0189
682 GASTRIC DISORDER 648 0.0189
683 MULTIPLE FRACTURES 309 0.0188
684 INJECTION SITE HAEMORRHAGE 1500 0.0188
685 PRESYNCOPE 456 0.0187
686 BLADDER DISORDER 186 0.0187
687 INTERNAL HAEMORRHAGE 214 0.0187
688 FEBRILE NEUTROPENIA 1241 0.0187
689 DYSPHONIA 1094 0.0187
690 HYPOXIA 658 0.0187
691 HEAD INJURY 589 0.0186
692 HAEMOPTYSIS 519 0.0186
693 BEDRIDDEN 244 0.0185
694 ATAXIA 220 0.0185
695 VITREOUS FLOATERS 182 0.0185
696 AGRANULOCYTOSIS 344 0.0185
697 BLOOD PRESSURE DECREASED 1225 0.0184
698 HEMIPARESIS 312 0.0184
699 ABASIA 455 0.0184
700 PNEUMOTHORAX 292 0.0184
701 COVID-19 3229 0.0184
702 DRUG EFFECT INCOMPLETE 667 0.0183
703 VISUAL IMPAIRMENT 2271 0.0183
704 CARDIAC FAILURE CONGESTIVE 1471 0.0183
705 RESTLESS LEGS SYNDROME 333 0.0183
706 INTENTIONAL DOSE OMISSION 522 0.0183
707 ORTHOSTATIC HYPOTENSION 318 0.0182
708 QUALITY OF LIFE DECREASED 245 0.0182
709 BLOOD BILIRUBIN INCREASED 493 0.0182
710 TOXIC EPIDERMAL NECROLYSIS 277 0.0182
711 EATING DISORDER 388 0.0182
712 MULTI-ORGAN FAILURE 315 0.0182
713 MELAENA 401 0.0182
714 ASCITES 535 0.0182
715 RENAL DISORDER 847 0.0182
716 URINARY RETENTION 606 0.0181
717 POLYNEUROPATHY 217 0.0181
718 DIABETES MELLITUS 1377 0.0180
719 RENAL FAILURE 2385 0.0179
720 POLLAKIURIA 749 0.0179
721 JAUNDICE 483 0.0179
722 TINNITUS 824 0.0179
723 SURGERY 1051 0.0179
724 RASH MACULAR 626 0.0179
725 RESPIRATORY FAILURE 1301 0.0178
726 GASTROINTESTINAL HAEMORRHAGE 1491 0.0178
727 ANGINA PECTORIS 508 0.0177
728 DRUG EFFECT DECREASED 953 0.0177
729 CHEST DISCOMFORT 1810 0.0177
730 EYE HAEMORRHAGE 235 0.0176
731 PRODUCT USE IN UNAPPROVED INDICATION 4350 0.0175
732 BALANCE DISORDER 1513 0.0175
733 SWELLING FACE 1136 0.0174
734 NEUTROPHIL COUNT DECREASED 711 0.0174
735 ERYTHEMA 3584 0.0174
736 EOSINOPHILIA 305 0.0174
737 DEAFNESS 455 0.0174
738 SYNCOPE 1731 0.0173
739 FEEDING DISORDER 350 0.0172
740 ABDOMINAL PAIN LOWER 436 0.0172
741 VERTIGO 1049 0.0172
742 DYSPHAGIA 1629 0.0171
743 ACTIVITIES OF DAILY LIVING IMPAIRED 339 0.0171
744 BLOOD TRIGLYCERIDES INCREASED 302 0.0171
745 HEPATOTOXICITY 377 0.0169
746 FLATULENCE 960 0.0169
747 RESPIRATORY DISTRESS 467 0.0169
748 LYMPHOPENIA 239 0.0169
749 GLOMERULAR FILTRATION RATE DECREASED 207 0.0168
750 PERITONITIS 348 0.0168
751 LOSS OF CONSCIOUSNESS 2152 0.0168
752 NEUTROPENIA 2282 0.0168
753 MUSCLE ATROPHY 212 0.0167
754 PARAESTHESIA ORAL 241 0.0167
755 UNDERDOSE 1218 0.0167
756 BURNING SENSATION 1170 0.0167
757 DYSARTHRIA 627 0.0166
758 MENTAL STATUS CHANGES 462 0.0166
759 INFLUENZA LIKE ILLNESS 1366 0.0166
760 DERMATITIS CONTACT 188 0.0165
761 LETHARGY 945 0.0164
762 ANXIETY 4665 0.0164
763 NEUROPATHY PERIPHERAL 1559 0.0164
764 CONSTIPATION 3573 0.0164
765 RETCHING 348 0.0163
766 RASH GENERALISED 421 0.0162
767 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2927 0.0162
768 HYPERTHYROIDISM 235 0.0162
769 BONE PAIN 950 0.0162
770 INSURANCE ISSUE 247 0.0161
771 COAGULOPATHY 269 0.0161
772 ILLNESS 1662 0.0161
773 APHASIA 487 0.0161
774 GENERALISED TONIC-CLONIC SEIZURE 266 0.0161
775 DIPLOPIA 417 0.0160
776 ILEUS 199 0.0160
777 NEOPLASM 184 0.0160
778 LUNG NEOPLASM MALIGNANT 654 0.0159
779 PRURITUS GENERALISED 343 0.0158
780 CIRCULATORY COLLAPSE 269 0.0158
781 RENAL IMPAIRMENT 1326 0.0158
782 THERAPEUTIC RESPONSE SHORTENED 522 0.0157
783 ANOREXIA 202 0.0157
784 HEAD DISCOMFORT 277 0.0156
785 LACRIMATION INCREASED 472 0.0156
786 FLUID OVERLOAD 227 0.0156
787 RASH ERYTHEMATOUS 745 0.0156
788 DEMENTIA 435 0.0155
789 ACUTE RESPIRATORY DISTRESS SYNDROME 275 0.0155
790 GAMMA-GLUTAMYLTRANSFERASE INCREASED 344 0.0155
791 EJECTION FRACTION DECREASED 239 0.0154
792 CARDIOGENIC SHOCK 220 0.0153
793 SENSORY DISTURBANCE 246 0.0153
794 PALPITATIONS 1788 0.0153
795 SKIN FISSURES 297 0.0152
796 SKIN REACTION 214 0.0152
797 ENCEPHALOPATHY 372 0.0151
798 CHOLESTASIS 290 0.0151
799 TREATMENT NONCOMPLIANCE 825 0.0151
800 MYALGIA 2550 0.0150
801 COLON CANCER 222 0.0149
802 PANCREATITIS ACUTE 333 0.0148
803 CARDIOMYOPATHY 217 0.0147
804 ISCHAEMIC STROKE 262 0.0147
805 BLINDNESS UNILATERAL 207 0.0147
806 SOMNOLENCE 2954 0.0147
807 THIRST 262 0.0146
808 SKIN HAEMORRHAGE 217 0.0146
809 DEVICE MALFUNCTION 1028 0.0146
810 SUBDURAL HAEMATOMA 209 0.0146
811 DRUG INTERACTION 2312 0.0146
812 DIABETES MELLITUS INADEQUATE CONTROL 258 0.0146
813 HYPOAESTHESIA ORAL 218 0.0144
814 PRODUCT DOSE OMISSION 944 0.0144
815 COORDINATION ABNORMAL 200 0.0143
816 ANAPHYLACTIC REACTION 792 0.0143
817 DERMATITIS 299 0.0143
818 COLD SWEAT 251 0.0142
819 METABOLIC ACIDOSIS 455 0.0142
820 CARDIAC FAILURE 1141 0.0142
821 SPEECH DISORDER 743 0.0142
822 CYANOSIS 223 0.0142
823 HYPERHIDROSIS 1825 0.0142
824 DISORIENTATION 561 0.0141
825 MUSCLE TIGHTNESS 229 0.0141
826 ECZEMA 737 0.0141
827 HOT FLUSH 1052 0.0139
828 FLUSHING 1415 0.0139
829 CARDIO-RESPIRATORY ARREST 581 0.0139
830 THERAPY CESSATION 713 0.0139
831 ERUCTATION 268 0.0138
832 MULTIPLE ORGAN DYSFUNCTION SYNDROME 392 0.0138
833 THERAPY INTERRUPTED 986 0.0138
834 DEPRESSED MOOD 729 0.0138
835 HAEMORRHAGE 1441 0.0138
836 SEIZURE 1591 0.0138
837 CEREBROVASCULAR ACCIDENT 2330 0.0137
838 ORAL DISCOMFORT 191 0.0137
839 TREMOR 2281 0.0137
840 ARRHYTHMIA 649 0.0137
841 ECONOMIC PROBLEM 206 0.0136
842 FEELING JITTERY 259 0.0136
843 HYPOGLYCAEMIA 653 0.0134
844 COGNITIVE DISORDER 628 0.0134
845 CARDIAC DISORDER 1258 0.0134
846 CONVULSION 767 0.0134
847 UNEVALUABLE EVENT 1013 0.0134
848 THROAT TIGHTNESS 362 0.0134
849 EYE PAIN 754 0.0134
850 EMOTIONAL DISORDER 411 0.0133
851 UNRESPONSIVE TO STIMULI 342 0.0132
852 DRUG DOSE OMISSION 2182 0.0132
853 PRODUCT PRESCRIBING ERROR 314 0.0132
854 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 937 0.0132
855 ACUTE MYELOID LEUKAEMIA 204 0.0131
856 BRADYCARDIA 682 0.0128
857 PROTEINURIA 244 0.0128
858 PULMONARY ARTERIAL HYPERTENSION 185 0.0128
859 DIALYSIS 181 0.0127
860 HYPOACUSIS 549 0.0127
861 AGEUSIA 317 0.0127
862 APATHY 185 0.0127
863 HALLUCINATION 955 0.0127
864 NIGHTMARE 438 0.0126
865 CARDIOVASCULAR DISORDER 321 0.0126
866 FEELING ABNORMAL 3022 0.0126
867 MIDDLE INSOMNIA 235 0.0126
868 VENTRICULAR TACHYCARDIA 207 0.0125
869 DYSGEUSIA 931 0.0125
870 DRUG LEVEL INCREASED 207 0.0125
871 LIP SWELLING 414 0.0124
872 ACCIDENTAL OVERDOSE 454 0.0124
873 INCORRECT DOSE ADMINISTERED 2825 0.0124
874 PHARYNGEAL OEDEMA 189 0.0123
875 MYOCARDIAL INFARCTION 2136 0.0122
876 OCULAR HYPERAEMIA 580 0.0122
877 METASTASES TO BONE 200 0.0122
878 HALLUCINATION, VISUAL 256 0.0121
879 BRAIN FOG 190 0.0121
880 PRODUCT AVAILABILITY ISSUE 275 0.0121
881 HYPERGLYCAEMIA 440 0.0121
882 NERVOUSNESS 629 0.0120
883 DISTURBANCE IN ATTENTION 648 0.0120
884 OSTEONECROSIS OF JAW 297 0.0120
885 METASTASES TO LIVER 209 0.0119
886 DYSKINESIA 482 0.0118
887 VISION BLURRED 1628 0.0118
888 DEVICE ISSUE 1063 0.0118
889 HOSPITALISATION 1818 0.0118
890 EYE SWELLING 440 0.0118
891 BLOOD CREATINE PHOSPHOKINASE INCREASED 340 0.0118
892 PRODUCT DOSE OMISSION ISSUE 3444 0.0117
893 MENTAL IMPAIRMENT 283 0.0117
894 DELUSION 181 0.0116
895 BONE DENSITY DECREASED 363 0.0116
896 CEREBRAL INFARCTION 283 0.0116
897 VAGINAL HAEMORRHAGE 497 0.0114
898 CYTOMEGALOVIRUS INFECTION 190 0.0114
899 INCREASED APPETITE 218 0.0114
900 CARDIAC ARREST 937 0.0113
901 PRODUCT DOSE OMISSION IN ERROR 321 0.0113
902 CHOKING 221 0.0113
903 BLINDNESS 459 0.0113
904 CEREBRAL HAEMORRHAGE 403 0.0112
905 INJECTION SITE MASS 415 0.0112
906 RENAL INJURY 333 0.0112
907 NEOPLASM MALIGNANT 745 0.0112
908 COMA 525 0.0110
909 PAIN OF SKIN 295 0.0109
910 FACE OEDEMA 184 0.0109
911 NEEDLE ISSUE 317 0.0109
912 INTENTIONAL PRODUCT MISUSE 953 0.0109
913 NERVOUS SYSTEM DISORDER 336 0.0108
914 VISUAL ACUITY REDUCED 356 0.0107
915 PELVIC PAIN 193 0.0106
916 RESTLESSNESS 387 0.0106
917 THERAPEUTIC RESPONSE UNEXPECTED 473 0.0105
918 SKIN EXFOLIATION 884 0.0105
919 OSTEONECROSIS 339 0.0103
920 STEVENS-JOHNSON SYNDROME 228 0.0102
921 EYE PRURITUS 344 0.0102
922 CRYING 370 0.0102
923 ANHEDONIA 266 0.0101
924 MOOD SWINGS 321 0.0101
925 BLOOD GLUCOSE ABNORMAL 186 0.0101
926 PLASMA CELL MYELOMA 392 0.0100
927 PANIC ATTACK 364 0.0100
928 MUSCLE TWITCHING 228 0.0099
929 HEPATIC FAILURE 298 0.0099
930 MENTAL DISORDER 428 0.0098
931 MENORRHAGIA 192 0.0098
932 ELECTROCARDIOGRAM QT PROLONGED 349 0.0097
933 DISEASE PROGRESSION 1147 0.0097
934 PSYCHOTIC DISORDER 285 0.0096
935 TOOTH LOSS 200 0.0096
936 FEAR 259 0.0096
937 PRODUCT ADMINISTRATION ERROR 194 0.0096
938 INCORRECT PRODUCT ADMINISTRATION DURATION 202 0.0093
939 AGITATION 684 0.0093
940 RHABDOMYOLYSIS 386 0.0092
941 DRY SKIN 1208 0.0090
942 MALIGNANT NEOPLASM PROGRESSION 923 0.0090
943 DISEASE RECURRENCE 427 0.0090
944 PRODUCT QUALITY ISSUE 1217 0.0090
945 BLOOD GLUCOSE INCREASED 1683 0.0089
946 BLOOD GLUCOSE DECREASED 427 0.0089
947 SUICIDAL IDEATION 805 0.0088
948 EYE IRRITATION 497 0.0086
949 ACNE 653 0.0086
950 MOOD ALTERED 232 0.0085
951 HEPATIC FUNCTION ABNORMAL 313 0.0084
952 AGGRESSION 415 0.0083
953 IRRITABILITY 498 0.0083
954 SHOCK 190 0.0083
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 452 0.0082
956 ABNORMAL DREAMS 220 0.0080
957 DEPRESSED LEVEL OF CONSCIOUSNESS 315 0.0080
958 ANGER 266 0.0079
959 ANAPHYLACTIC SHOCK 202 0.0078
960 ANGIOEDEMA 345 0.0078
961 DEVICE DISLOCATION 336 0.0077
962 NEOPLASM PROGRESSION 268 0.0077
963 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 196 0.0076
964 MULTIPLE SCLEROSIS 357 0.0075
965 ABNORMAL BEHAVIOUR 290 0.0073
966 DEATH 6287 0.0073
967 TOXICITY TO VARIOUS AGENTS 1216 0.0072
968 BREAST CANCER 669 0.0072
969 ERECTILE DYSFUNCTION 183 0.0071
970 RESPIRATORY ARREST 196 0.0071
971 OVERDOSE 1530 0.0071
972 LACTIC ACIDOSIS 218 0.0067
973 MYELOSUPPRESSION 236 0.0065
974 DRUG ADMINISTRATION ERROR 193 0.0063
975 MULTIPLE SCLEROSIS RELAPSE 415 0.0060
976 SKIN IRRITATION 270 0.0059
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1098 0.0054
978 PROSTATE CANCER 415 0.0052
979 PRODUCT SUBSTITUTION ISSUE 296 0.0051
980 WITHDRAWAL SYNDROME 207 0.0049
981 DEVICE LEAKAGE 208 0.0048
982 EMOTIONAL DISTRESS 580 0.0048
983 SUICIDE ATTEMPT 279 0.0046
984 ACCIDENTAL EXPOSURE TO PRODUCT 465 0.0045
985 SKIN BURNING SENSATION 311 0.0043
986 PRODUCT STORAGE ERROR 338 0.0039
987 NO ADVERSE EVENT 632 0.0035
988 DRUG ABUSE 245 0.0029
989 INTENTIONAL OVERDOSE 188 0.0029
990 COMPLETED SUICIDE 186 0.0022
991 DRUG DEPENDENCE 228 0.0014